イシグロ タイチ
ISHIGURO Taichi
石黒 太一 所属 医学部 医学科(附属八千代医療センター) 職種 准教授 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Outcome of Endovascular Therapy Aiming for Single-session Obliteration of Intracranial Dural Arteriovenous Fistulas. |
掲載誌名 | 正式名:Neurologia medico-chirurgica 略 称:Neurol Med Chir (Tokyo) ISSNコード:13498029/04708105 |
掲載区分 | 国外 |
巻・号・頁 | 61(10),pp.563-569 |
著者・共著者 | Ishiguro Taichi, Satow Tetsu, Hamano Eika, Ikeda Go, Chikuie Hidekazu, Hashimura Naoki, Nishimura Masaki, Takahashi Jun C, Kataoka Hiroharu |
担当区分 | 筆頭著者 |
発行年月 | 2021/10 |
概要 | The goal of dural arteriovenous fistula (dAVF) treatment is obliteration of the arteriovenous shunt and/or retrograde leptomeningeal venous drainage (RLVD). Single-session obliteration could improve symptoms early and reduce risk of neurological sequelae. This study investigated the efficacy and adverse events of endovascular therapy (EVT) aiming for single-session obliteration in dAVF treatment. We retrospectively examined post-treatment arteriovenous shunt status, number of treatments per case, treatment-related complications, and long-term outcome in 92 dAVF patients who underwent initial EVT at our institution. Single-session obliteration was intended in all cases, but a second session was performed in cases of partial shunt occlusion or remaining RLVD. Complete occlusion was achieved in 85 cases (92.4%) after the single session; RLVD was obliterated in 66 of the 67 Borden type II and III cases combined (98.5%). A second session was necessary in seven cases (7.6%). Complete shunt obliteration was eventually achieved in all cases. The average number of treatments was 1.08 per case. dAVF-related stroke and mortality did not occur after the treatment. On the other hand, radiation-induced skin erythema and alopecia, although all symptoms were transient, occurred in 26 cases (28.3%). Over an average 60.2-month follow-up period, recurrence was observed in seven cases (7.6%). Single-session obliteration was successful in 92% of cases. Especially, single-session obliteration of RLVD may contribute to early prevent of future stroke events. However, reducing total radiation dose during each session is an issue of further study. |
DOI | 10.2176/nmc.oa.2021-0059 |
PMID | 34148944 |